RUBERTI, GIOVINA
 Distribuzione geografica
Continente #
AS - Asia 1.508
NA - Nord America 899
EU - Europa 394
SA - Sud America 245
AF - Africa 28
OC - Oceania 2
Totale 3.076
Nazione #
US - Stati Uniti d'America 863
SG - Singapore 622
CN - Cina 325
BR - Brasile 203
VN - Vietnam 167
HK - Hong Kong 141
IT - Italia 134
FR - Francia 84
KR - Corea 69
JP - Giappone 36
DE - Germania 34
IN - India 33
GB - Regno Unito 30
NL - Olanda 28
BD - Bangladesh 26
FI - Finlandia 23
AT - Austria 16
CA - Canada 13
AR - Argentina 12
EC - Ecuador 12
IL - Israele 12
IQ - Iraq 12
ZA - Sudafrica 11
MX - Messico 10
TR - Turchia 9
ID - Indonesia 8
SE - Svezia 8
CO - Colombia 7
ES - Italia 7
IE - Irlanda 7
PK - Pakistan 7
PL - Polonia 7
UZ - Uzbekistan 7
PA - Panama 5
RU - Federazione Russa 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
TN - Tunisia 4
JO - Giordania 3
PH - Filippine 3
UA - Ucraina 3
VE - Venezuela 3
AZ - Azerbaigian 2
BH - Bahrain 2
DZ - Algeria 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
SA - Arabia Saudita 2
SN - Senegal 2
YT - Mayotte 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
FJ - Figi 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SZ - Regno dello Swaziland 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UG - Uganda 1
UY - Uruguay 1
Totale 3.076
Città #
Singapore 356
Santa Clara 299
Hong Kong 137
Hefei 128
San Jose 112
Rome 79
Seoul 68
Lauterbourg 63
Ashburn 55
Hanoi 52
Beijing 50
Los Angeles 50
Ho Chi Minh City 49
New York 29
Tokyo 26
Dallas 24
Orem 19
Munich 12
São Paulo 12
Chennai 11
Turku 11
Brooklyn 10
Da Nang 9
Frankfurt am Main 9
Rio de Janeiro 9
Haiphong 8
London 8
Manchester 8
Minamishinagawa 8
Stockholm 8
Vienna 8
Buffalo 7
Denver 7
Düsseldorf 7
Helsinki 7
Milan 7
Tashkent 7
Ankara 6
Chicago 6
Dublin 6
Johannesburg 6
Nanjing 6
Baghdad 5
Boston 5
Campinas 5
Quận Bình Thạnh 5
Quận Năm 5
Belo Horizonte 4
Bengaluru 4
Brasília 4
Curitiba 4
Guarulhos 4
Lappeenranta 4
Medellín 4
Melito di Napoli 4
Ninh Bình 4
Salvador 4
Thái Bình 4
Warsaw 4
Amman 3
Amsterdam 3
Bari 3
Bauru 3
Betim 3
Biên Hòa 3
Cape Town 3
Foshan 3
Houston 3
Hải Dương 3
Montreal 3
Mumbai 3
Nuremberg 3
Osasco 3
Phoenix 3
Poplar 3
Quito 3
Ribeirão Preto 3
Suzano 3
Vũng Tàu 3
Ahmedabad 2
Atlanta 2
Bady Bassitt 2
Baku 2
Bogotá 2
Bến Tre 2
Campo Novo do Parecis 2
Caracas 2
Catanduva 2
Cleveland 2
Colombo 2
Concepción 2
Cotia 2
Council Bluffs 2
Currais Novos 2
Dakar 2
Dubai 2
Edison 2
Goiânia 2
Guayaquil 2
Henderson 2
Totale 1.974
Nome #
Drug effects on metabolic profiles of Schistosoma mansoni adult male parasites detected by 1H-NMR spectroscopy 101
MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells. 93
Establishment and characterization of EGFR Tyrosine Kinase Inhibitor-resistant lung cancer cell lines 77
Integrated analysis of DNA copy number and gene expression data in Lung Cancer models of resistance to targeted therapy 74
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors 73
Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems. 70
Crystal structures of Schistosoma mansoni histone deacetylase 8 reveal a novel binding site for allosteric inhibitors 67
GSE80344: Gene expression profiling of Erlotinib sensitive and resistant human non small cell lung cancer (NSCLC) cell lines 65
Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages 64
Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells. 63
Discovery by organism based high-throughput screening of new multi-stage compounds affecting Schistosoma mansoni viability, egg formation and production. 62
Co-Expression Network Analysis Unveiled lncRNA-mRNA Links Correlated to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance and/or Intermediate Epithelial-to-Mesenchymal Transition Phenotypes in a Human Non-Small Cell Lung Cancer Cellular Model System 62
Thiazinoquinones as New Promising Multistage Schistosomicidal Compounds Impacting Schistosoma mansoni and Egg Viability. 61
Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production 61
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation 55
Chemical Investigation of the Indonesian Tunicate Polycarpa aurata and Evaluation of the Effects Against Schistosoma mansoni of the Novel Alkaloids Polyaurines A and B. 55
CASP4 gene silencing in epithelial cancer cells leads to impairment of cell migration, cell-matrix adhesion and tissue invasion. 54
The activity of a PI3K ?-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway. 54
Use of Perhexiline 53
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability 53
IDDM12 Locus analysis in T1DM: identification and characterization of functional polymorphisms 53
Development and Validation of a Luminescence-based, Medium-Throughput Assay for Drug Screening in Schistosoma mansoni. 53
Screening and phenotypical characterization of Schistosoma mansoni histone deacetylase 8 (SmHDAC8) inhibitors as multi-stage antischistosomal agents 52
(+)-(R)- and (-)-(S)-Perhexiline maleate: Enantioselective synthesis and functional studies on Schistosoma mansoni larval and adult stages 52
Investigating the Antiparasitic Potential of the Marine Sesquiterpene Avarone, Its Reduced form Avarol, and the Novel Semisynthetic Thiazinoquinone Analogue Thiazoavarone 51
Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines 51
In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines 51
Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model 50
DNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis. 50
Integrated analysis of DNA copy number and gene expression data in Lung cancer models of resistance to targeted therapy 49
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation 49
N-Terminal and C-Terminal Domains of Calmodulin Mediate FADD and TRADD Interaction. 43
FADD-calmodulin interaction: A novel player in cell cycle regulation. 41
Comparative metabolic profiling by H-1-NMR spectroscopy analysis reveals the adaptation of S. mansoni from its host to in vitro culture conditions: a pilot study with ex vivo and GSH-supplemented medium-cultured parasites 41
Co-ordinator report, JDRF-Telethon Project IDDM locus analysis in T1DM- Identification and characterization of functional polymorphisms , 2006-07 41
SELECTION FOR AMINO-ACID-SEQUENCE AND J-BETA-ELEMENT USAGE IN THE BETA-CHAIN OF DBA 2V BETA(B)-DERIVED AND DBA 2V BETA(A)-DERIVED MYOGLOBIN-SPECIFIC T-CELL CLONES 41
Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis 39
Luminescence-based, low- and medium-throughput assays for drug screening in schistosoma mansoni larval stage 38
Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. 37
Rendicontazione scientifica FBdQ_Laboratorio di Riferimento Farmaci innovativi - Modelli cellulari e murini II 35
An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. 35
Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. 33
The 3' UTR of the human CTLA4 mRNA can regulate mRNA stability and translational efficiency. 32
Fas gene polymorphisms are not associated with systemic lupus erythematosus, multiple sclerosis and HIV infection 32
Fas and Fas ligand-mediated apoptosis and its role in autoimmune diabetes 30
Ricerca di molecole schistosomicide. Progetto "Creazione di un Centro per la ricerca di nuovi farmaci per malattie rare, trascurate e della povertà"-­- SP1-­-WP1 CNCCS-­-CNR_II Report 2014 30
CD95 ligand expression on alpha cells: protection or killing? 29
Ricerca di molecole schistosomicide. Progetto "Creazione di un Centro per la ricerca di nuovi farmaci per malattie rare, trascurate e della povertà"-­- SP1-­-WP1 CNCCS-­-CNR_I Report 2014 27
Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome 27
Soluble Fas/Apo-1 splicing variants and apoptosis 25
DETECTION OF POLYMORPHISMS WITHIN THE FAS CDNA GENE SEQUENCE BY GC-CLAMP DENATURING GRADIENT GEL-ELECTROPHORESIS 25
Schistosomiasi malattia parassitaria negletta: identificazione di nuovi bersagli epigenetici. I Report 2014 25
Ricerca di molecole schistosomicide. Progetto "Creazione di un Centro per la ricerca di nuovi farmaci per malattie rare, trascurate e della povertà"-­- SP1-­-WP1 CNCCS-­-CNR_II Report 2013 25
The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis 24
Schistosomiasi malattia parassitaria negletta: identificazione di nuovi bersagli epigenetici_II Report 2014 24
The European Innovative Medicines Initiative 24
Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor 24
Co-ordinator report, CNR Ricerca a tema libero project, 2005 - FADD e TRADD nell'immunità naturale 24
ANALYSIS OF THE TERNARY COMPLEX OF ANTIGEN, MHC AND T-CELL RECEPTOR - THE INFLUENCE OF THE T-CELL RECEPTOR V-BETA REPERTOIRE ON THE V-BETA GENE ELEMENT USAGE 24
RESISTANCE TO GEMCITABINE IN A LYMPHOMA CELL LINE RESISTANT TO FAS-MEDIATED APOPTOSIS 24
Co-ordinator report, Juvenile Diabets Research Foundation (JDRF), Innovative USA Grant - "Role of T1DM-associated CTLA-4 Polymorphisms on protein Trafficking and Compartmentalization" 23
CD95 and CD95-ligand expression in endocrine pancreas of NOD, NOR and BALB/c mice. 23
Rendicontazione scientifica FBdQ_Laboratorio di Riferimento Farmaci innovativi - Modelli cellulari e murini I anno 23
Unit co-ordinator report, MIUR-CNR Project Genomica Funzionale-Funzioni di gruppo di geni a livello cellulare e di organismo- U.O. COMETA-COntrollo e Modulazione della Trasduzione del segnale apoptotico 23
Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. 23
Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness. 22
Reduced cumulative incidence of diabetes but not insulitis following administration of chimeric human IL-15-murine IgG2b in NOD mice 22
Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. 21
MOLECULAR ANALYSIS OF THE ROLE OF THE HLA CLASS-II GENES DRB1, DQA1, DQB1, AND DPB1 IN SUSCEPTIBILITY TO LYME ARTHRITIS 21
Potential involvement of fas and its ligand in the pathogenesis of Hashimoto's thyroiditis 21
Rendicontazione scientifica FBdQ_Laboratorio di Riferimento Farmaci innovativi - Modelli cellulari e murini 20
THE T-CELL RECEPTOR REPERTOIRE INFLUENCES V-BETA ELEMENT USAGE IN RESPONSE TO MYOGLOBIN 20
Ricerca di molecole schistosomicide. Progetto "Creazione di un Centro per la ricerca di nuovi farmaci per malattie rare, trascurate e della povertà"-­- SP1-­-WP1 CNCCS-­-CNR_I Report 2013 20
Ricerca di molecole schistosomicide. Progetto "Creazione di un Centro per la ricerca di nuovi farmaci per malattie rare, trascurate e della povertà"-­- SP1-­-WP1 CNCCS-­-CNR_II Report 2012 18
PRESENTATION OF ANTIGEN BY MIXED ISOTYPE CLASS-II MOLECULES IN NORMAL H-2D MICE 17
null 17
null 12
Totale 3.123
Categoria #
all - tutte 9.838
article - articoli 7.684
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 45
Totale 17.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202447 0 0 0 0 0 0 0 0 1 0 38 8
2024/20251.255 5 6 90 44 282 40 38 104 53 51 297 245
2025/20261.821 97 135 152 316 348 74 285 71 122 124 97 0
Totale 3.123